Rubicon Organics Becomes Largest Organic Licensed Producer in Canada
February 5th, 2019
Exclusive, News, Top News
Organic is a buzzword, a trend, an ethos that reflects a healthy approach to life. It’s also a certification that has real value in the world. In the cannabis industry, that value is reflected in a market where certified organic cannabis commands upwards of an 80% price premium in Canada. Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB), one of the largest cannabis companies in the world, recently recognized the intrinsic value of organic products when it agreed to buy Whistler Medical Marijuana Corporation (“Whistler Medical”) for C$175 million. Whistler Medical became Canada’s first certified organic licensed producer (“LP”) in 2014.
Rubicon Organics Inc. (CSE: ROMJ) (OTCQX: ROMJF) became, on February 1st, 2019, Canada’s fourth organic licensed producer, and its licensed organic footprint is currently the largest of any of the four companies’. Rubicon Organics’ Co-Founder and CEO, Jesse McConnell, was also the Co-Founder of Whistler Medical. The company’s Chief Scientific Officer, Peter Doig, wrote the certification standard for organic cannabis in Canada and designed Whistler’s original cultivation system. Together, they have figured out how to produce organic cannabis in high-yield hybrid greenhouses at an ultra-low cost of C$0.50/gram.
Organic Production is Difficult
With the built-in upside of higher margins, it is fair to wonder why more companies aren’t growing organic cannabis. The answer, of course, is that organic production at scale is incredibly difficult. Of the 150 or so licenses currently awarded by Health Canada, only four companies are organic. It takes diligent commitment, advanced systems, and a nuanced understanding of cannabis plant growth to raise organic crops at an industrial level.
Rubicon Organics has developed a proprietary production system that allows for high quality, consistent production of super-premium organic cannabis at an extremely low cost. Rubicon Organics asserts it can grow cannabis for C$0.50/gram. As a reference, Aphria Inc. (TSX: APHA) (NYSE: APHA) is touted as one of the industry’s lowest cost producers. According to an article in Marketwatch, the company was reporting cash costs to produce a gram of dried flower between C$0.90 and C$1.30, while selling grams for an average of about C$9.00. According to Statistics Canada, the average price for a gram of cannabis sold by legal suppliers, since full legalization, is C$9.70. On the BC Cannabis Stores site, you can buy a gram of Whistler Medical’s organic CBD Shark strain for C$17.99.
Hitting the Ground Running
Rubicon Organics has a head start out of the gates relative to typical newly licensed producers. Under the Cannabis Act the company is able to begin with an extensive proven genetic library of 1000’s of strains, and Rubicon Organics is already under production. The company has existing operations in both California and the state of Washington, with brands and product lines that have already been proven in those markets. When Rubicon harvests its first crop from its 125,000 sqft hybrid greenhouse facility in British Columbia, it will already have the product formulations and branding plans worked out. That BC facility has been specifically designed to be the best of both worlds by utilizing industry leading LED technology and supplemental sunlight, allowing Rubicon to produce super-premium quality at scale.
Rubicon Organic’s licenses cover both cultivation and processing, meaning the company will be able to immediately turn some of that super-premium cannabis into even higher-margin derivative products based on oils and extracts. The company’s Washington brand, Doctor & Crook, already specializes in processing cannabis concentrates for both the medical and recreational markets out of its own 40,000 sqft facility.
Rubicon Organic’s branding efforts are logically focused in California, especially in the trend-setting Southern California market. Its 1964 Supply Co. brand saturates the retail cannabis market in the area, partnering with artists for visually engaging packaging and sponsoring events like the International Surf Festival to cement its cool and hip image. The company’s plan is to marry the SoCal vibe with the eminently marketable BC organic cannabis products to create an internationally powerful brand.
Rubicon Organics’ recent licensing by Health Canada is a huge step forward in the company’s plan to become an international organic cannabis powerhouse. The company is positioned to capitalize on the overall trend to organics in an explosive, young industry that lacks significant competition for the organic slice of the cannabis market pie. By marrying proprietary organic growing systems with the most advanced hybrid greenhouse technology, Rubicon Organics is set to make a huge splash. Stay tuned for further developments.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.